Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Ryo Saito, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura (Kansai Medical University, Osaka, Japan)
Session information
Oral Session
Oral Session 3-11D MDS:AZA Treatment
Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.11 (Tokyo International Forum, 5F G502)
Chair: Tomoko Hata (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University)
Chiaki Naito, Hiroaki Shimizu, Takuma Ishizaki, Akihiko Yokohama, Takayuki Saito, Hiroshi Handa (Dept. of Hematology, Gunma University Hospital)
Kazuto Ogura, Junko Akagawa, Tasuku Saito, Sumiko Kobayashi, Shigesaburo Miyakoshi (Department of Hematology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan)
Aya Nakano1, Takeshi Saito1, Hiroki Yokoyama1, Atsushi Katsube1, Hiroto Ishii1, Tadahiro Gunji1, Sayaka Oshima1, Shoko Ishii1, Riku Nagao1, Noriko Usui2, Kaichi Nishiwaki3, Nobuaki Dobashi2, Shingo Yano1 (1.Clinical Oncol/Hematol, the Jikei Univ Hosp., Tokyo, Japan, 2.Clinical Oncol/Hematol, the Jikei Univ Daisan Hosp., Tokyo, Japan, 3.Clinical Oncol/Hematol, the Jikei Univ Kashiwa Hosp., Chiba, Japan)
Yukitsugu Nakamura1,2, Yoshitomo Kushima1, Dasisuke Asahara1 (1.Int. Med., Japanese Red Cross Ashikaga Hospital., Ashikaga, Japan, 2.Ishimoto Hospital, Ishii, Kasama, Ibaraki, Japan)
Shinichi Ogawa1, Kana Miyamoto1, Yasuko Ogino1, Takayoshi Itoh1, Yasuhito Nanya2, Seishi Ogawa2, Manabu Kusakabe3, Shigeru Chiba3 (1.JA Toride General Medical Center, 2.Department of Pathology and Tumor Biology, Kyoto University, 3.Department of Hematology, University of Tsukuba)